Reply to Tran et al.: Dimeric KRAS protein-protein interaction stabilizers
- PMID: 32047042
- PMCID: PMC7035485
- DOI: 10.1073/pnas.1921236117
Reply to Tran et al.: Dimeric KRAS protein-protein interaction stabilizers
Conflict of interest statement
Competing interest statement: D.K., A.G., M.G., A.M., L.J.M., A.Z., M.M., D.C., S.F., T. Gerstberger, T. Gmaschitz, P.G., D.H., W.H., J.H., J.K.-O., P.K., S.K., M.K., R.K., L.L., F.M., S.M.-M., C.P., J.R., C.S., Y.S., K.S., R.S., A.S., B.S., G.S., B.W., M.Z., M.P., and D.B.M. were employees of Boehringer Ingelheim at the time of the work.
Figures

Comment on
-
Drugging an undruggable pocket on KRAS.Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15823-15829. doi: 10.1073/pnas.1904529116. Epub 2019 Jul 22. Proc Natl Acad Sci U S A. 2019. PMID: 31332011 Free PMC article.
-
The small molecule BI-2852 induces a nonfunctional dimer of KRAS.Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3363-3364. doi: 10.1073/pnas.1918164117. Epub 2020 Feb 11. Proc Natl Acad Sci U S A. 2020. PMID: 32047043 Free PMC article. No abstract available.
Similar articles
-
Remodeling KRAS.Structure. 2017 Sep 5;25(9):1323-1324. doi: 10.1016/j.str.2017.08.012. Structure. 2017. PMID: 28877504
-
Dual Targeting of Autophagy and MEK in KRAS Mutant Cancer.Trends Cancer. 2019 Jun;5(6):327-329. doi: 10.1016/j.trecan.2019.04.003. Epub 2019 May 7. Trends Cancer. 2019. PMID: 31208693
-
Kirsten Ras* oncogene: significance of its discovery in human cancer research.Oncotarget. 2016 Jul 19;7(29):46717-46733. doi: 10.18632/oncotarget.8773. Oncotarget. 2016. PMID: 27102293 Free PMC article. Review.
-
Reply to Costs of ALK, ROS1, EGFR, and KRAS testing in non-small cell lung cancer: About different strategies in France.Cancer Cytopathol. 2017 Nov;125(11):877. doi: 10.1002/cncy.21918. Epub 2017 Sep 11. Cancer Cytopathol. 2017. PMID: 28892267 No abstract available.
-
Targeting Mutant KRAS for Anticancer Therapy.Curr Top Med Chem. 2019;19(23):2098-2113. doi: 10.2174/1568026619666190902151307. Curr Top Med Chem. 2019. PMID: 31475898 Review.
Cited by
-
RAS Nanoclusters: Dynamic Signaling Platforms Amenable to Therapeutic Intervention.Biomolecules. 2021 Mar 3;11(3):377. doi: 10.3390/biom11030377. Biomolecules. 2021. PMID: 33802474 Free PMC article. Review.
-
Mechanism of activation and the rewired network: New drug design concepts.Med Res Rev. 2022 Mar;42(2):770-799. doi: 10.1002/med.21863. Epub 2021 Oct 25. Med Res Rev. 2022. PMID: 34693559 Free PMC article. Review.
-
Inhibition of Nonfunctional Ras.Cell Chem Biol. 2021 Feb 18;28(2):121-133. doi: 10.1016/j.chembiol.2020.12.012. Epub 2021 Jan 12. Cell Chem Biol. 2021. PMID: 33440168 Free PMC article. Review.
-
SI/II Pocket of Ras: An Opportunity for a Once "Undruggable" Target.ACS Omega. 2025 Feb 28;10(9):9463-9473. doi: 10.1021/acsomega.4c10493. eCollection 2025 Mar 11. ACS Omega. 2025. PMID: 40092832 Free PMC article.
-
Crystal Packing Reveals a Potential Autoinhibited KRAS Dimer Interface and a Strategy for Small-Molecule Inhibition of RAS Signaling.Biochemistry. 2023 Nov 21;62(22):3206-3213. doi: 10.1021/acs.biochem.3c00378. Epub 2023 Nov 8. Biochemistry. 2023. PMID: 37938120 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous